Market Tracker

09/26 6:18am ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

127.22
Delayed Data
As of Sep 23
 -6.47 / -4.84%
Today’s Change
110.56
Today|||52-Week Range
193.45
-33.31%
Year-to-Date

Today’s Trading

Previous close133.69
Today’s open131.60
Day’s range127.18 - 132.30
Volume2,154,637
Average volume (3 months)1,792,450
Market cap$28.5B
Dividend yield--
Data as of 09/23/2016

Growth & Valuation

Earnings growth (last year)-79.45%
Earnings growth (this year)-7.16%
Earnings growth (next 5 years)+24.20%
Revenue growth (last year)+12.25%
P/E ratio424.1
Price/Sales16.57
Price/Book3.48

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...-0.71-1.47%
ZTSZoetis Inc-0.12-0.23%
MYLMylan NV-0.53-1.24%
VRTXVertex Pharmaceutica...-1.49-1.62%
Data as of 09/23/2016

Financials

Next reporting dateOctober 20, 2016
EPS forecast (this quarter)$1.17
Annual revenue (last year)$2.5B
Annual profit (last year)$144.4M
Net profit margin5.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
New Haven, Connecticut

Forecasts